Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

5290 ARTíCULOS , VIENDO DEL 136 AL 150

PUBMED

Novel Substituted Heteroaryl Compounds for Treating Huntington's Disease

Sabnis RW.

ACS Med Chem Lett. 2021 Nov 15;12(12):1881-1882. doi: 10.1021/acsmedchemlett.1c00607. eCollection 2021 Dec 9.

0

0

0

PUBMED

Case Report: HSV-2 Encephalitis Presenting With Chorea; Effects of Infection Alone or Combination of Infection and Autoimmunity?

Kolesnik M, Ballout AA, Hameed N, Najjar S.

Front Neurol. 2021 Dec 10;12:790514. doi: 10.3389/fneur.2021.790514. eCollection 2021.

0

0

0

PUBMED

Hyperglycemic chorea

Sasaki T, Suzuki Y, Sato M.

Oxf Med Case Reports. 2021 Dec 11;2021(11):omab118. doi: 10.1093/omcr/omab118. eCollection 2021 Nov.

0

0

0

PUBMED

Gene Therapy for Polyglutamine Spinocerebellar Ataxias: Advances, Challenges, and Perspectives

Vázquez-Mojena Y, León-Arcia K, González-Zaldivar Y, Rodríguez-Labrada R, Velázquez-Pérez L.

Mov Disord. 2021 Dec;36(12):2731-2744. doi: 10.1002/mds.28819. Epub 2021 Oct 10.

0

0

0

PUBMED

Glia: A major player in glutamate-GABA dysregulation-mediated neurodegeneration

Sood A, Preeti K, Fernandes V, Khatri DK, Singh SB.

J Neurosci Res. 2021 Dec;99(12):3148-3189. doi: 10.1002/jnr.24977. Epub 2021 Nov 8.

0

0

0

PUBMED

Interweaving of Reactive Oxygen Species and Major Neurological and Psychiatric Disorders

Umare MD, Wankhede NL, Bajaj KK, Trivedi RV, Taksande BG, Umekar MJ, Mahore JG, Kale MB.

Ann Pharm Fr. 2021 Dec 9:S0003-4509(21)00175-9. doi: 10.1016/j.pharma.2021.11.004. Online ahead of print.

0

0

0

PUBMED

Exploring the Role of Orexinergic Neurons in Parkinson's Disease

Kumar S, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harassi A, Abdel-Daim MM, Bungau S.

Neurotox Res. 2021 Dec;39(6):2141-2153. doi: 10.1007/s12640-021-00411-4. Epub 2021 Sep 8.

0

0

0

PUBMED

Neuroglobin and neuroprotection: the role of natural and synthetic compounds in neuroglobin pharmacological induction

Ciccone L, Nencetti S, Socci S, Orlandini E.

Neural Regen Res. 2021 Dec;16(12):2353-2358. doi: 10.4103/1673-5374.300981.

0

0

0

PUBMED

Repurposing Vorinostat for the Treatment of Disorders Affecting Brain

Athira KV, Sadanandan P, Chakravarty S.

Neuromolecular Med. 2021 Dec;23(4):449-465. doi: 10.1007/s12017-021-08660-4. Epub 2021 May 4.

0

0

0

PUBMED

Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies

Domin H.

Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110349. doi: 10.1016/j.pnpbp.2021.110349. Epub 2021 May 13.

0

0

0

PUBMED

Cooperation of cell adhesion and autophagy in the brain: Functional roles in development and neurodegenerative disease

Hernandez SJ, Fote G, Reyes-Ortiz AM, Steffan JS, Thompson LM.

Matrix Biol Plus. 2021 Oct 23;12:100089. doi: 10.1016/j.mbplus.2021.100089. eCollection 2021 Dec.

0

0

0

PUBMED

Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?

Ostapiuk A, Urbanska EM.

CNS Neurosci Ther. 2022 Jan;28(1):19-35. doi: 10.1111/cns.13768. Epub 2021 Dec 3.

0

0

0

PUBMED

Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases

González LF, Bevilacqua LE, Naves R.

Pharmaceutics. 2021 Dec 1;13(12):2055. doi: 10.3390/pharmaceutics13122055.

0

0

0

PUBMED

Aptamer Applications in Neuroscience

Ozturk M, Nilsen-Hamilton M, Ilgu M.

Pharmaceuticals (Basel). 2021 Dec 3;14(12):1260. doi: 10.3390/ph14121260.

0

0

0

PUBMED

Genetically modified large animal models for investigating neurodegenerative diseases

Yang W, Chen X, Li S, Li XJ.

Cell Biosci. 2021 Dec 21;11(1):218. doi: 10.1186/s13578-021-00729-8.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy